|
|
Article: Selecta Co-Founder Named 2009 Mass High Tech All Star.
- Article from:
- Vaccine Weekly
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Selecta Biosciences, Inc., a biopharmaceutical company focused on discovering and developing the first generation of nanoparticle-based vaccines and immunomodulatory drugs for the treatment and prevention of human diseases, announced that Omid Farokhzad, M.D., co-founder and Vice Chair, has been named as a 2009 Mass High Tech All Star for his contributions to the life sciences industry. Now in its fourteenth year, the annual All Star awards program recognizes dynamic and influential leaders across several business and technology sectors in New England's innovation economy. This year's honorees are profiled in a special supplement of Mass High Tech: The Journal of New ...
Related newspaper, magazine, and journal articles:
|
|
Article: New England: State of mind or going concern?
Connection, New England's Journal of Higher Education;
October 1, 1998 ;
700+ words
... ... Greater Boston, where I direct a New England Public Policy Collaborative (NEPPC ... So you might say the state of New England is just "a state of mind." But my gut tells me the state of New England should be a going concern. The ...
|
|